-
1
-
-
70350105624
-
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression
-
Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, et al. Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 2009; 18: 2694-2700.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 2694-2700
-
-
Hoque, M.O.1
Prencipe, M.2
Poeta, M.L.3
Barbano, R.4
Valori, V.M.5
Copetti, M.6
-
2
-
-
33744960226
-
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
-
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
-
(2006)
JAMA
, vol.295
, pp. 2492-2502
-
-
Carey, L.A.1
Perou, C.M.2
Livasy, C.A.3
Dressler, L.G.4
Cowan, D.5
Conway, K.6
-
3
-
-
79960833408
-
Tyrosine phosphatases in the HER2directed motility of ovarian cancer cells
-
Villa-Moruzzi E. Tyrosine phosphatases in the HER2directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK. Anal Cell Pathol 2011; 34: 101-112.
-
(2011)
Involvement of PTPN12, ERK5 and FAK. Anal Cell Pathol
, vol.34
, pp. 101-112
-
-
Villa-Moruzzi, E.1
-
4
-
-
77955861826
-
PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells
-
Espejo R, Rengifo-Cam W, Schaller MD, Evers BM, Sastry SK. PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells. Am J Physiol Cell Physiol 2010; 299: C454-C463.
-
(2010)
Am J Physiol Cell Physiol
, vol.299
-
-
Espejo, R.1
Rengifo-Cam, W.2
Schaller, M.D.3
Evers, B.M.4
Sastry, S.K.5
-
5
-
-
34447529493
-
Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells
-
Sahu SN, Nunez S, Bai G, Gupta A. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. Am J Physiol Cell Physiol 2007; 292: C2288-C2296.
-
(2007)
Am J Physiol Cell Physiol
, vol.292
-
-
Sahu, S.N.1
Nunez, S.2
Bai, G.3
Gupta, A.4
-
6
-
-
79952292499
-
Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase
-
Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, et al. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 2011; 144: 703-718.
-
(2011)
Cell
, vol.144
, pp. 703-718
-
-
Sun, T.1
Aceto, N.2
Meerbrey, K.L.3
Kessler, J.D.4
Zhou, C.5
Migliaccio, I.6
-
7
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
8
-
-
33847065486
-
The epigenomics of cancer
-
Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692.
-
(2007)
Cell
, vol.128
, pp. 683-692
-
-
Jones, P.A.1
Baylin, S.B.2
-
9
-
-
0034895071
-
Over expression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
-
Milde-Langosch K, Bamberger AM, Rieck G, Kelp B, Löning T. Over expression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat 2001; 67: 61-70.
-
(2001)
Breast Cancer Res Treat
, vol.67
, pp. 61-70
-
-
Milde-Langosch, K.1
Bamberger, A.M.2
Rieck, G.3
Kelp, B.4
Löning, T.5
-
10
-
-
79960671119
-
Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay
-
Chae BJ, Bae JS, Yim HW, Lee A, Song BJ, Jeon HM, et al. Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay. Pathology 2011; 43: 248-253.
-
(2011)
Pathology
, vol.43
, pp. 248-253
-
-
Chae, B.J.1
Bae, J.S.2
Yim, H.W.3
Lee, A.4
Song, B.J.5
Jeon, H.M.6
-
11
-
-
33847147313
-
American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-145.
-
(2007)
J Clin Oncol
, vol.25
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
-
12
-
-
33748333091
-
PTP-PEST phosphatase variations in human cancer
-
Streit S, Ruhe JE, Knyazev P, Knyazeva T, Iacobelli S, Peter S, et al. PTP-PEST phosphatase variations in human cancer. Cancer Genet Cytogenet 2006; 170: 48-53.
-
(2006)
Cancer Genet Cytogenet
, vol.170
, pp. 48-53
-
-
Streit, S.1
Ruhe, J.E.2
Knyazev, P.3
Knyazeva, T.4
Iacobelli, S.5
Peter, S.6
-
13
-
-
36549029229
-
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
-
Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, et al. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 2007; 9: R57.
-
(2007)
Breast Cancer Res
, vol.9
-
-
Feng, W.1
Shen, L.2
Wen, S.3
Rosen, D.G.4
Jelinek, J.5
Hu, X.6
|